TMEM5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.817000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.883200E-01
Normal-vs-Stage2
6.602000E-01
Normal-vs-Stage3
8.830400E-02
Normal-vs-Stage4
8.951200E-01
Stage1-vs-Stage2
7.738100E-03
Stage1-vs-Stage3
5.248100E-02
Stage1-vs-Stage4
3.587600E-01
Stage2-vs-Stage3
8.183800E-02
Stage2-vs-Stage4
5.364400E-01
Stage3-vs-Stage4
6.819600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.383400E-01
Normal-vs-AfricanAmerican
9.280400E-01
Normal-vs-Asian
1.529960E-01
Caucasian-vs-AfricanAmerican
7.233600E-01
Caucasian-vs-Asian
8.417300E-03
AfricanAmerican-vs-Asian
6.715800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.472400E-01
Normal-vs-Female
6.763600E-01
Male-vs-Female
7.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.490800E-01
Normal-vs-Age(41-60Yrs)
2.330400E-01
Normal-vs-Age(61-80Yrs)
8.361400E-01
Normal-vs-Age(81-100Yrs)
8.960600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.935800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.288800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.263200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.249820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.013400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.989800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.889570E-01
Normal-vs-Daily Drinker
7.005400E-01
Normal-vs-Weekly Drinker
6.163000E-01
Normal-vs-Occasional Drinker
6.253000E-01
Normal-vs-Social Drinker
3.726600E-01
Non Drinker-vs-Daily Drinker
3.137400E-01
Non Drinker-vs-Weekly Drinker
6.267000E-01
Non Drinker-vs-Occasional Drinker
1.789550E-02
Non Drinker-vs-Social Drinker
2.553400E-01
Daily Drinker-vs-Weekly Drinker
7.886200E-01
Daily Drinker-vs-Occasional Drinker
1.000950E-01
Daily Drinker-vs-Social Drinker
3.138400E-01
Weekly Drinker-vs-Occasional Drinker
1.125200E-01
Weekly Drinker-vs-Social Drinker
2.937000E-01
Occasional Drinker-vs-Social Drinker
5.011200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.191200E-01
Normal-vs-Grade 2
6.178000E-01
Normal-vs-Grade 3
8.829800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.057400E-01
Grade 1-vs-Grade 3
9.465700E-02
Grade 1-vs-Grade 4
6.191200E-01
Grade 2-vs-Grade 3
6.920200E-01
Grade 2-vs-Grade 4
6.178000E-01
Grade 3-vs-Grade 4
8.829800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.009200E-01
Normal-vs-NonDiabetic
5.466200E-01
Diabetic-vs-NonDiabetic
1.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.995700E-02
Normal-vs-NoPancreatitis
5.946200E-01
Pancreatitis-vs-NoPancreatitis
7.204600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.380600E-01
Normal-vs-N1
7.581600E-01
N0-vs-N1
2.172600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.977800E-01
Normal-vs-TP53-NonMutant
1.368970E-01
TP53-Mutant-vs-TP53-NonMutant
5.385900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
